Results

Total Results: 643 records

Showing results for "adverse events".
Users also searched for: patient safety indicators

1. Evidence Summary: Prevention of Acquisition of HIV: Preexposure Prophylaxis | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
   August 22, 2023 - events (7.5% vs 6.9%) or study drug discontinuation due to adverse events (1.5% vs 1.9%). … events or grade 3 or higher adverse events ( Table 2 ; eTables 1-4 in the  JAMA  Supplement). 6 , 7 … liver-related adverse events, or STIs. … events, discontinuation due to adverse events, or any adverse event: 1 new RCT (n = 5387) Serious … adverse events: 7% vs 7% Discontinuation due to adverse events: 1% vs 2% Any adverse event: 94% vs 94%

2. Final Evidence Summary: Hepatitis C Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-c-screening
   March 02, 2020 - events (1.9%) and withdrawal due to adverse events (0.4%). … of therapy). 12-55 Adverse Events in Comparative Trials. … due to adverse events, headache, or fatigue. … Rates of other adverse events were highly variable. … events There was 1 serious adverse event (grade 3 joint injury) in 1 study The rate of any adverse

3. Evidence Summary: Nonpregnant Adolescents and Adults: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nonpregnant-adolescents-and-adults1/human-immunodeficiency-virus-hiv-infection-screening
   June 11, 2019 - use based on 4 cohort studies, including the Data Collection on Adverse Events of Anti-HIV Drugs (D: … Hepatic and Renal Adverse Events Analysis of data from the D:A:D study (n = 45,544) found long-term … Some new evidence also indicates that long-term hepatic, renal, and bone (fracture) adverse events are … Mocroft A, Lundgren JD, Ross M, et al; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study … Comparative safety and neuropsychiatric adverse events associated with efavirenz use in first-line antiretroviral

4. Screening for HIV Infection in Asymptomatic, Nonpregnant Adolescents and Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/q_zxLD9JZFGoSPCrEHNk2g
   June 11, 2019 - events with abacavir use based on 4 cohort stud- ies, including the Data Collection on Adverse Events … Hepatic and Renal Adverse Events Analysis of data from the D:A:D study (n = 45 544) found long- term … Some new evidence also indicates that long-term hepatic, renal, and bone (fracture) adverse events are … Mocroft A, Lundgren JD, Ross M, et al; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study … Comparative safety and neuropsychiatric adverse events associated with efavirenz use in first-line antiretroviral

5. Archived: Final Research Plan: Chlamydia and Gonorrhea: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan21/chlamydia-and-gonorrhea-screening-september-2014
   June 15, 2013 - Analytic Framework (Text Description) This analytic framework is a diagram that depicts the events … During the screening, they may experience adverse events, they may be diagnosed with a gonococcal or … Analytic Framework (Text Description) This analytic framework is a diagram that depicts the events … During the screening, they may experience adverse events, they may be diagnosed with a gonococcal or … chlamydia infection, and they may go through treatment, which could lead to adverse effects.

6. Draft Research Plan: Chronic Kidney Disease: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/chronic-kidney-disease-screening
   January 19, 2023 - change in albuminuria) KQs 1, 4, 6: Progression to stage 4 or stage 4/5 CKD KQs 2, 5, 8: Any adverse … events Serious adverse events Specific adverse events Renal adverse events KQs 3, 3a:

7. Archived: Evidence Summary: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
   June 11, 2019 - PrEP was associated with an increased risk of renal adverse events (12 trials; RR, 1.43 [95% CI, 1.18 … -1.75]; I 2 = 0%; ARD, 0.56% [95% CI, 0.09%-1.04%]) and gastrointestinal adverse events (12 trials; … RR, 1.63 [95% CI, 1.26-2.11]; I 2 = 43%; ARD, 1.95% [95% CI, 0.48%-3.43%]); most adverse events were … However, for both of these adverse events there was only 1 trial of tenofovir disoproxil fumarate. … events Good Most trials did not report withdrawals resulting from adverse events Composite outcome

8. Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/bQNXFv9Q5uaAQvWH6B7VWV
   June 11, 2019 - PrEP was associated with an increased risk of renal adverse events (12 trials; RR, 1.43 [95% CI, 1.18 … -1.75]; I2 = 0%; ARD, 0.56% [95% CI, 0.09%-1.04%]) and gastrointestinal adverse events (12 trials; RR … , 1.63 [95% CI, 1.26-2.11]; I2 = 43%; ARD, 1.95% [95% CI, 0.48%-3.43%]); most adverse events were mild … PrEP was associated with increased risk vs placebo of renal adverse events (12 trials [n = 18 170]; … events Good Most trials did not report withdrawals resulting from adverse events Composite outcome,

9. Evidence Summary: Hepatitis B Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-b-virus-infection-screening
   December 15, 2020 - events (7 trials, n = 3136), 35 , 38 , 40 , 41 , 43 , 82 withdrawal due to adverse events (7 trials … events (RR, 2.41 [95% CI, 0.86 to 6.74]), withdrawal due to adverse events (RR, 4.01 [95% CI, 0.86 to … events or experiencing any adverse event vs placebo. … adverse events vs lamivudine, consistent with known adverse effects of interferon-based therapies. … to adverse events: 3 trials, n = 496; RR, 4.44 (95% CI, 0.95-20.77); I 2 =0% 22 , 24 , 27 Any adverse

10. Archived: Tobacco Smoking Cessation in Adults, Including Pregnant Women: Behavioral and Pharmacotherapy Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions-september-2015
    September 21, 2015 - The USPSTF also evaluated adverse events reported at any time point. … Adverse events related to other forms of behavioral interventions were not reported. … 1.24 [CI, 0.85 to 1.81]) or major cardiovascular adverse events (RR, 1.44 [CI, 0.73 to 2.83]). … events related to product use or any difference in the frequency of adverse events. 8 One study 30 … Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation.

11. Archived: Final Research Plan: Tobacco Smoking Cessation in Adults, Including Pregnant Women: Behavioral and Pharmacotherapy Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan88/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions-september-2015
    February 18, 2014 - individuals with mental health conditions, lead to improved health outcomes, tobacco abstinence, or adverse … events.   … What adverse events are associated with tobacco cessation interventions? … events Serious treatment-related harms at any time point after the intervention began … events associated with medications Paradoxical increase in tobacco use Demoralization

12. Recommendation: Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions
    January 19, 2021 - Cardiac adverse events and other serious adverse events did not differ by type of NRT. 63 The USPSTF … events (RR, 1.30 [95% CI, 1.00-1.69]; 33 trials; n = 9631), 83 cardiovascular adverse events (RR, 1.03 … events or cardiovascular severe adverse events was found. 13 Additionally, no statistically significant … Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. … be associated with an increased risk of general severe adverse events.

13. Final Research Plan: Chronic Kidney Disease: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/chronic-kidney-disease-screening
    July 13, 2023 - change in albuminuria) KQs 1, 4, 6: Progression to stage 4 or stage 4/5 CKD KQs 2, 5, 8: Any adverse … events Serious adverse events Specific adverse events Renal adverse events KQs 3, 3a:

14. Archived: Final Research Plan: Colorectal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan54/colorectal-cancer-screening-june-2016
    April 17, 2014 - b) Do adverse effects vary by important subpopulations (e.g., by age)? … events requiring unexpected or unwanted medical attention and/or resulting in death (e.g., requiring … including but not limited to perforation, major bleeding, severe abdominal symptoms, and cardiovascular events … ; extra-colonic findings and subsequent diagnostic workup and adverse events from diagnostic testing … events defined as those not necessarily needing or resulting in medical attention (e.g., patient dissatisfaction

15. Evidence Summary: Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions
    January 19, 2021 - None of the drugs were associated with serious adverse events. … events, including major cardiovascular adverse events or serious neuropsychiatric events, as compared … events NRT was associated with a higher rate of any cardiovascular adverse events, largely driven … events, particularly cardiovascular- or neuropsychiatric-specific adverse events Adverse events typically … events NA Very few reviews assessed adverse events related to behavioral interventions Moderate

16. Evidence for the Reaffirmation of the USPSTF Recommendaiton on Screening for High Blood Pressure (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/KSYrhQuAswGjTww_4sDFGZ
    December 01, 2007 - events are uncommon. … Serious adverse effects were uncommon, and 2 of the 3 reported events were probably not related to the … due to adverse events was 11%. … Other adverse events were hyperkalemia in 2 eplerenone recipients and 1 amlodipine recipient, and hypokalemia … events are uncommon.

17. Archived: Evidence Summary: Blood Pressure in Adults (Hypertension): Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary15/blood-pressure-in-adults-hypertension-screening-2007
    October 15, 2007 - events are uncommon. … Serious adverse effects were uncommon, and 2 of the 3 reported events were probably not related to the … due to adverse events was 11%. … Other adverse events were hyperkalemia in 2 eplerenone recipients and 1 amlodipine recipient, and hypokalemia … events are uncommon.  

18. Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/xUc_vXf7323faUQY7SePhT
    January 01, 2002 - and its likelihood of causing adverse effects. … the participants had definite or suspected vascular disease.12,13 From our search for articles on adverse … Adverse Effects of Aspirin Therapy Hemorrhagic stroke. … effect of aspirin, a reduction in nonfatal myocardial infarction, cannot be directly equated to an adverse … Adverse effects of low-dose aspirin in a healthy elderly population.

19. Final Research Plan: Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cardiovascular-disease-screening-using-nontraditional-risk-assessment
    September 03, 2015 - factor assessment or treatment based on nontraditional risk factor assessment are associated with any adverse … events (KQ3 and KQ5). … risk factors—followed by treatment specific to risk level—lead to reduced incidence of cardiovascular events … c-statistic), and calibration (e.g., agreement between observed and predicted risks) KQs 3, 5: Serious adverse … events from risk factor assessment or aggressive risk factor modification resulting in unexpected or

20. T6Tquunynv3Twm65Bfash2 (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/T6Tquunynv3tWM65BFash2
    October 01, 2015 - The USPSTF also evaluated adverse events reported at any time point. … Adverse events related to other forms of behavioral in- terventions were not reported. … events (RR, 1.24 [CI, 0.85 to 1.81]) or major cardiovascular adverse events (RR, 1.44 [CI, 0.73 to 2.83 … events related to product use or any difference in the frequency of adverse events (8). … Adverse events associated with nicotine replacement therapy (NRT) for smoking ces- sation.